Industry
Drug Manufacturers - Specialty & Generic
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
Loading...
Open
1.24
Mkt cap
14M
Volume
8.9K
High
1.25
P/E Ratio
-3.49
52-wk high
2.75
Low
1.21
Div yield
N/A
52-wk low
1.15
Portfolio Pulse from Avi Kapoor
August 26, 2024 | 11:36 am
Portfolio Pulse from Benzinga Newsdesk
August 12, 2024 | 8:21 pm
Portfolio Pulse from Benzinga Newsdesk
May 10, 2024 | 8:07 pm
Portfolio Pulse from Benzinga Insights
March 04, 2024 | 2:44 pm
Portfolio Pulse from Benzinga Insights
February 12, 2024 | 2:44 pm
Portfolio Pulse from Benzinga Insights
December 25, 2023 | 2:43 pm
Portfolio Pulse from Benzinga Insights
November 27, 2023 | 2:43 pm
Portfolio Pulse from Benzinga Newsdesk
November 14, 2023 | 9:57 pm
Portfolio Pulse from richadhand@benzinga.com
August 17, 2023 | 3:48 pm
Portfolio Pulse from Benzinga Newsdesk
August 14, 2023 | 10:58 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.